Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Alexey Dobrodeev"'
Autor:
Nataliya Babyshkina, Nataliya Popova, Evgeny Grigoryev, Tatyana Dronova, Polina Gervas, Alexey Dobrodeev, Dmitry Kostromitskiy, Victor Goldberg, Sergei Afanasiev, Nadejda Cherdyntseva
Publikováno v:
Drug Target Insights, Vol 18, Iss 1 (2024)
Immunotherapy has become an integral part of a comprehensive treatment approach to metastatic colorectal cancer (mCRC). Nivolumab (Opdivo) is a human immunoglobulin G4 monoclonal antibody that blocks the interaction between the programmed cell death
Externí odkaz:
https://doaj.org/article/3a8b6f17462045d08f866d5fe967bc4f
Autor:
Irina Larionova, Marina Patysheva, Pavel Iamshchikov, Elena Kazakova, Anna Kazakova, Militsa Rakina, Evgeniya Grigoryeva, Anna Tarasova, Sergei Afanasiev, Natalia Bezgodova, Artem Kiselev, Alexey Dobrodeev, Dmitriy Kostromitskiy, Nadezhda Cherdyntseva, Julia Kzhyshkowska
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
IntroductionCirculating monocytes are main source for tumor-associated macrophages (TAMs) that control tumor growth, angiogenesis, metastasis and therapy resistance. We raised the questions how monocyte programming is affected by growing tumors local
Externí odkaz:
https://doaj.org/article/0e81c6e705ce471a92a5059c8f0b33ea
Autor:
Alexey Dobrodeev, Sergei Afanas’ev, L. V. Spirina, Dmitry Kostromitsky, Olga V Cheremisina, Alexandra Avgustinovich, Maxim Volkov
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 11176, p 11176 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 20
International Journal of Molecular Sciences
Volume 22
Issue 20
Introduction: The programmed death receptor ligand 1 (PD-L1) immunohistochemistry (IHC) assay is a widely used selection method for pembrolizumab treatment in gastric cancer (GC) patients. PD-L1 is the main regulator of immunity in oncogenesis. Mater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a688b59aeb6683480132d95296105a1d
https://doi.org/10.3390/ijms222011176
https://doi.org/10.3390/ijms222011176
Publikováno v:
Scopus-Elsevier
ResearcherID
ResearcherID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::65c47cbfe3d4c21650a2292a38f247e4
http://www.scopus.com/inward/record.url?eid=2-s2.0-77954656125&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-77954656125&partnerID=MN8TOARS
Publikováno v:
ResearcherID
Scopus-Elsevier
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::812ab0668640f4d5e766c611a93c9a6f
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=MEDLINE&KeyUT=MEDLINE:24300605&KeyUID=MEDLINE:24300605
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=MEDLINE&KeyUT=MEDLINE:24300605&KeyUID=MEDLINE:24300605
Publikováno v:
Scopus-Elsevier
ResearcherID
ResearcherID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::30d789405ce333db1ef3f1144d32b240
http://www.scopus.com/inward/record.url?eid=2-s2.0-84891644799&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84891644799&partnerID=MN8TOARS
Autor:
Cherdyntseva, N. V., Gervas, P. A., Litvyakov, N. V., Stakcheeva, M. N., Ponomaryeva, A. A., Alexey Dobrodeev, Denisov, E. V., Belyavskaya, V. A., Choinzonov, E. L.
Publikováno v:
Scopus-Elsevier
ResearcherID
ResearcherID
Aim: To examine the influence of combined genotypes of TP53 (exon 4, intron 3, intron 6) and XRCC1 (codon 10) on lung cancer age of onset. Methods: TP53 polymorphisms in codon 72 of exon 4 (Arg72Pro), in intron 3 (16 bp duplication), in intron 6 (G/A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::07bcc02a01afe3d5a9eb82d7e8066d8c
http://www.scopus.com/inward/record.url?eid=2-s2.0-77957738564&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-77957738564&partnerID=MN8TOARS